Literature DB >> 8944178

Triosephosphate isomerase deficiency: predictions and facts.

F Orosz1, B G Vértessy, S Hollán, M Horányi, J Ovádi.   

Abstract

Deficiencies in around 20 enzymes, associated with widely different degrees of severity and complexity, have been identified for human erythrocytes. The fact that glycolysis is crucial for erythrocyte function is reflected by the large number of inherited glycolytic enzymopathies. Triosephosphate isomerase (TPI) deficiency, a rare autosomal disease, is usually associated with nonspherocytic hemolytic anemia, progressive neurologic dysfunction, and death in childhood. The two affected Hungarian brothers studied by us have less than 3% TPI activity and enormously (30-50-fold) increased dihydroxyacetone phosphate (DHAP) concentration in their erythrocytes. The well-established concept of the metabolic control theory was used to test the contribution of TPI and some related enzymes to the control of a relevant segment of the glycolytic pathway in normal and deficient cells. Deviation indices, DEJ = (delta J/delta E) E(r)/J(r), which give a good estimation of flux control coefficients using a single large change in enzyme activity, were determined from the fluxes in the absence and presence of exogeneous enzymes. We found that PFK and aldolase are the enzymes that predominantly control the flux, however, the quantitative values depend extensively on the pH: DEJ values are 0.85 and 0.14 at pH 8.0 and 0.33 and 0.67 at pH 7.2 for aldolase and PFK, respectively. Neither the flux rates nor the capacities of the enzymes seem to be significantly different in normal and TPI deficient cells. There is a discrepancy between DHAP levels and TPI activities in the deficient cells. In contrast to the experimental data the theoretical calculations predict elevation in DHAP level at lower than 0.1% of the normal value of TPI activity. Several possibilities suggested fail to explain this discrepancy. Specific associations of glycolytic enzymes to band-3 membrane proteins with their concomitant inactivation have been demonstrated. We propose that the microcompartmentation of TPI that could further decrease the reduced isomerase activity of the deficient cells, is responsible for the high DHAP level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944178     DOI: 10.1006/jtbi.1996.0184

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  5 in total

1.  Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei.

Authors:  S Helfert; A M Estévez; B Bakker; P Michels; C Clayton
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Authors:  F Orosz; G Wágner; K Liliom; J Kovács; K Baróti; M Horányi; T Farkas; S Hollán; J Ovádi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 3.  Advanced stoichiometric analysis of metabolic networks of mammalian systems.

Authors:  Mehmet A Orman; Francois Berthiaume; Ioannis P Androulakis; Marianthi G Ierapetritou
Journal:  Crit Rev Biomed Eng       Date:  2011

4.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

5.  Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency.

Authors:  Joanna Segal; Michael Mülleder; Antje Krüger; Thure Adler; Manuela Scholze-Wittler; Lore Becker; Julia Calzada-Wack; Lillian Garrett; Sabine M Hölter; Birgit Rathkolb; Jan Rozman; Ildiko Racz; Ralf Fischer; Dirk H Busch; Frauke Neff; Martin Klingenspor; Thomas Klopstock; Nana-Maria Grüning; Steve Michel; Beata Lukaszewska-McGreal; Ingo Voigt; Ludger Hartmann; Bernd Timmermann; Hans Lehrach; Eckhard Wolf; Wolfgang Wurst; Valérie Gailus-Durner; Helmut Fuchs; Martin H de Angelis; Heinrich Schrewe; Mariia Yuneva; Markus Ralser
Journal:  J Inherit Metab Dis       Date:  2019-06-11       Impact factor: 4.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.